In lung adenocarcinoma, FDX1 was a part of the electron transport chain risk signature predicting prognosis and was a regulator of glucose metabolism, fatty acid oxidation, and amino acid metabolism (Zhang et al., 2021). Here, FDX1 is linked to lung adenocarcinoma.